Targeted Glycan Degradation Potentiates Cellular Immunotherapy for Solid Tumors

The combination of cancer cell desialylation and induced pluripotent stem cell–derived chimeric antigen receptor–macrophage adoptive cellular therapy exerted a dramatic therapeutic effect on solid tumors and significantly prolonged the survival of tumor-bearing mice.
[Proceedings Of The National Academy Of Sciences Of The United States Of America]

Stay up-to-date with your field!

Subscribe for free weekly science newsletters.

Related News